Health and Fitness Health and Fitness
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Lilly Introduces Global 'Innovation Starts Here' .. itiative to Foster Innovation and Quality Science
[ Tue, Feb 28th 2012 ] - Market Wire
Hi-Tech Pharmacal to Present at the 2012 RBC Capital Marketsa Global Healthcare Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Alchemia to Present at the Cowen Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Dendreon Announces Executive Appointments
[ Tue, Feb 28th 2012 ] - Market Wire
Keryx Biopharmaceuticals, Inc. to Host Conference .. ourth Quarter and Year-End 2011 Financial Results
[ Tue, Feb 28th 2012 ] - Market Wire
Exactech 2011 Revenue Up 8% to $205M;; Net .. EPS $0.67;; Q4 Net Income $1.8M, EPS $0.14
[ Tue, Feb 28th 2012 ] - Market Wire
Cerus Corporation Reports Fourth Quarter and Year-End 2011 Results
[ Tue, Feb 28th 2012 ] - Market Wire
Ironwood Pharmaceuticals Provides Fourth Quarter 2011 Investor Update
[ Tue, Feb 28th 2012 ] - Market Wire
OncoGenex to Webcast Discussion of Fourth Quarter .. 2011 Financial Results on Thursday, March 8, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
UNITEDHEALTHCARE FORTALECER EL SERVICIO EN FLORID .. RA DE PREFERRED CARE PARTNERS Y MEDICA HEALTHCARE
[ Tue, Feb 28th 2012 ] - Market Wire
Quest Diagnostics Declares Quarterly Cash Dividend
[ Tue, Feb 28th 2012 ] - Market Wire
Nordion to Release First Quarter 2012 Financial Results
[ Tue, Feb 28th 2012 ] - Market Wire
Lucid, Inc. Announces Separation of Unit to Common Stock and Warrant
[ Tue, Feb 28th 2012 ] - Market Wire
Lieff Cabraser Heimann & Bernstein, LLP Reminds I .. in Class Action Lawsuit Against Chemed Corporati
[ Tue, Feb 28th 2012 ] - Market Wire
Healthways to Present at the Barclays Capital Global Healthcare Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Metropolitan Health Networks to Announce Fourth Quarter and Fiscal 2011 Results
[ Tue, Feb 28th 2012 ] - Market Wire
LED Dental Announces Partnership With Edelman
[ Tue, Feb 28th 2012 ] - Market Wire
Biogen Idec presenta solicitud a la FDA para apro .. oral para el tratamiento de la esclerosis mltiple
[ Tue, Feb 28th 2012 ] - Market Wire
Quest Diagnostics to Speak at the 2012 RBC Capital Markets Healthcare Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Cowen 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Judgment Issued in Crucell N.V. Buy-Out Proceedings
[ Tue, Feb 28th 2012 ] - Market Wire
BIOLASE Announces Preliminary Fourth Quarter Results
[ Tue, Feb 28th 2012 ] - Market Wire
Johnson amp;; Johnson to Participate in Co .. en and Company 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Johnson & Johnson to Participate in Cowen and Company 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
BIOLASE Announces Agreement With Henry Schein for .. ng Inventory of Hard-Tissue Lasers, the Waterlase
[ Tue, Feb 28th 2012 ] - Market Wire
AdCare Health Systems to Present at the ROTH Capi .. Partners 24th Annual Conference on March 12, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Teva to Present at the 2012 RBC Capital Marketsa Global Healthcare Conference
[ Tue, Feb 28th 2012 ] - Market Wire
AVI BioPharma Announces FDA Approval to Proceed W .. Dosing of AVI-6003 for Treatment of Marburg Virus
[ Tue, Feb 28th 2012 ] - Market Wire
Oncothyreon Announces Full Year and Fourth Quarter 2011 Financial Results Conference Call

Oncothyreon Announces Full Year and Fourth Quarter 2011 Financial Results Conference Call


Published on 2012-02-28 05:15:30 - Market Wire
  Print publication without navigation


Oncothyreon Announces Full Year and Fourth Quarter 2011 Financial Results Conference Call

Oncothyreon Announces Full Year and Fourth Quarter 2011 Financial Results Conference Call

[ ]

SEATTLE, Feb. 28, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: [ ONTY ]) today announced that it will conduct a conference call to discuss its full year and fourth quarter 2011 financial results and provide a review of its pipeline of products in development on Tuesday, March 6, 2012 at 4:30 p.m. Eastern Time.

To participate in the call by telephone, please dial (877) 280-7291 (United States) or (707) 287-9361 (International). In addition, the call will be webcast live and can be accessed on the "Events" page of the "News & Events" section of Oncothyreon's website at [ www.oncothyreon.com ]. An archive of the webcast will be available after completion of the discussion and will be posted on the Oncothyreon website.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit [ www.oncothyreon.com ].

SOURCE Oncothyreon Inc.

[ Back to top ]

Contributing Sources